Geode Capital Management LLC Reduces Holdings in Tilray Inc (NASDAQ:TLRY)

Geode Capital Management LLC cut its position in Tilray Inc (NASDAQ:TLRY) by 4.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,002,540 shares of the company’s stock after selling 88,161 shares during the quarter. Geode Capital Management LLC’s holdings in Tilray were worth $4,348,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in TLRY. BNP Paribas Financial Markets grew its stake in Tilray by 1,314.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock valued at $3,202,000 after purchasing an additional 1,690,827 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in shares of Tilray during the 3rd quarter valued at approximately $1,348,000. Bank of Montreal Can grew its position in shares of Tilray by 19.6% during the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock worth $3,622,000 after buying an additional 355,778 shares in the last quarter. XTX Topco Ltd increased its stake in shares of Tilray by 1,079.7% in the third quarter. XTX Topco Ltd now owns 281,504 shares of the company’s stock worth $495,000 after buying an additional 257,641 shares during the last quarter. Finally, Barclays PLC raised its holdings in Tilray by 600.4% in the third quarter. Barclays PLC now owns 204,144 shares of the company’s stock valued at $359,000 after acquiring an additional 174,997 shares in the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Stock Performance

Shares of TLRY opened at $1.45 on Monday. The stock has a market capitalization of $1.31 billion, a PE ratio of -5.37 and a beta of 2.08. The business’s fifty day moving average price is $1.40 and its 200 day moving average price is $1.63. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. Tilray Inc has a 12-month low of $1.14 and a 12-month high of $2.97.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.04). The company had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The company’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same period last year, the firm posted ($0.10) EPS. Equities research analysts forecast that Tilray Inc will post -0.14 EPS for the current year.

Insider Activity

In related news, CFO Carl A. Merton acquired 26,000 shares of Tilray stock in a transaction that occurred on Friday, November 15th. The stock was acquired at an average price of $1.36 per share, for a total transaction of $35,360.00. Following the transaction, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at $35,360. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.87% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Roth Mkm decreased their price objective on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a report on Friday, October 11th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.